Why Amazon Pulls Supplement Listings: The Testing and Documentation Failures Behind Most Suspensions

We’ve had supplement brands call us in a panic more times than I can count. The story is almost always the same: a product that had been selling well suddenly gets a listing suspension notice, the seller scrambles to figure out what went wrong, and they discover that the compliance documentation they thought was sufficient actually wasn’t — not by Amazon’s current standards.

Amazon has quietly become one of the most rigorous gatekeepers in the US supplement market. More rigorous, in several respects, than the FDA’s minimum enforcement posture under 21 CFR Part 111. That’s not a criticism of Amazon — it’s a reality that brands need to internalize, because sellers who treat the platform like a passive storefront get blindsided when Amazon starts enforcing its Dietary Supplement Quality and Safety policies at scale.

Here’s what we see in practice, broken down by failure type.

The COA Problem: Documentation That Looks Compliant But Isn’t

The Certificate of Analysis (COA) sits at the center of Amazon’s supplement verification process. Most brands know they need one. Far fewer understand what a compliant COA actually looks like under Amazon’s current requirements.

Amazon requires COAs from third-party laboratories that are ISO/IEC 17025:2017 accredited and genuinely independent of the manufacturer or brand. That means a COA generated by your contract manufacturer’s in-house quality department — even a well-resourced one — does not meet the standard. Neither does testing from a lab that shares ownership, infrastructure, or financial relationships with the manufacturer. Amazon has suspended listings specifically because the “third-party” lab turned out to be a division of the same parent company as the contract manufacturer.

The second issue is currency. COAs go stale. Amazon generally expects documentation that reflects the specific lot currently being sold, not a COA from a batch produced 18 months earlier. We see brands assume that a passing result from an earlier run covers ongoing production. It doesn’t — not if your formulation, ingredient supplier, or manufacturing site has changed, and often not even if none of those things have changed.

Third: scope. A COA that only addresses identity, or only covers microbiological limits, typically won’t satisfy a full Amazon compliance review. Depending on the product type, Amazon may expect the documentation to address identity, potency (label claim verification), microbial limits, and heavy metal content — all generated by the same accredited lab under the same accreditation scope. A patchwork of partial COAs from different sources rarely holds up under review.

Label Claim Failures: The Problem That Often Predates the Listing

This is the failure category that surprises brands most, because it reveals a quality issue that frequently predates the Amazon relationship entirely.

Under 21 CFR Part 111 — the FDA’s Current Good Manufacturing Practice regulations for dietary supplements — manufacturers are required to test each production batch for identity, purity, strength, and composition before release. “Strength” means the product should deliver what the label says it delivers, in the amount stated. In practice, independent potency testing regularly finds products that fall outside acceptable tolerances. Sometimes dramatically so.

We’ve tested finished supplement batches where the active ingredient concentration came in below 50% of the labeled claim. We’ve also seen the opposite: products delivering significantly more than labeled, which creates its own regulatory exposure. Certain nutrients — vitamin A and vitamin D are the clearest examples — have established Tolerable Upper Intake Levels (ULs) set by the National Academies of Sciences, Engineering, and Medicine where chronic overconsumption becomes a genuine safety concern, not just a labeling technicality.

Amazon’s policies reflect consumer protection expectations that operate largely independently of FDA enforcement activity. A brand may have been operating for years without an FDA inquiry, but a consumer complaint or an Amazon spot-check program can surface a label claim failure immediately. The upstream fix is straightforward: run label claim verification testing with an independent ISO 17025 accredited lab before any product goes live on any sales channel — not as a response to a suspension notice.

Microbial and Contaminant Results: What Brands Least Expect to See

If potency failures are surprising, microbial and contaminant results can be genuinely alarming. The operating assumption for most brands is that a cGMP-compliant contract manufacturer is controlling contamination adequately. Often they are. But cGMP compliance and clean finished-product test results are not the same guarantee.

USP General Chapters <61> (Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests) and <62> (Microbiological Examination of Nonsterile Products: Tests for Specified Microorganisms) define the test methods and acceptance criteria for dietary supplement microbial testing. Acceptable limits vary by dosage form — tablets, capsules, and oral powders each carry different specifications — but the core requirement is consistent: finished products must be free of specified pathogens including Salmonella spp., E. coli, and Staphylococcus aureus, and total aerobic plate counts must fall within defined limits.

Herbal raw materials are a particularly high-risk input. Botanicals sourced from regions with variable agricultural water quality standards arrive with microbial loads that can survive tableting or encapsulation if in-process controls are insufficient. We’ve documented finished-product failures on lots where the raw material supplier’s COA showed a passing result — because the supplier’s COA was generated from a different sub-lot, or because the test method wasn’t equivalent to USP <61>.

On the chemical side: heavy metals (arsenic, cadmium, lead, mercury) remain a persistent issue in botanical supplements, protein powders, and products containing mineral ingredients. California Proposition 65 sets maximum allowable dose levels for lead and other listed chemicals that are substantially stricter than general federal guidance — and brands distributing nationally through Amazon are selling to California consumers regardless of where the brand is headquartered. That exposure is real and needs to be tested for, not assumed away.

What Amazon Actually Requires From Your Third-Party Lab

Amazon’s quality testing requirements for dietary supplements aren’t spelled out with the same granularity as an FDA guidance document, but the core lab requirements that appear in Seller Central policies and compliance notices are consistent:

ISO/IEC 17025:2017 accreditation with the right scope. The lab must hold current accreditation from a recognized accreditation body — in the US, the American Association for Laboratory Accreditation (A2LA) and Perry Johnson Laboratory Accreditation (PJLA) are among the most recognized ILAC-MRA signatories. Critically, the accreditation scope must cover the specific methods being performed. A lab holding accreditation for environmental water chemistry is not a qualified source for a dietary supplement identity and potency COA.

Genuine operational independence. No financial relationship, shared management, or common ownership between the testing lab and the manufacturer or brand submitting the COA. This is enforced more strictly than many sellers expect.

Method citation. COAs that reference the specific test method — a USP chapter number, an AOAC method, or a validated in-house method with documented validation data — carry significantly more weight than COAs that report a result without method attribution. Amazon reviewers increasingly flag method-absent documentation.

Lot-specific traceability. The COA must identify the exact production batch or lot number that corresponds to the inventory being sold. Generic or “master” COAs covering a product formulation broadly, without lot-specific traceability, have been rejected in reinstatement reviews.

One logistical detail that brands consistently underestimate: the testing timeline. A complete finished supplement panel — identity, potency across all labeled actives, USP <61>/<62> microbiology, and ICP-MS heavy metals — typically runs 10 to 20 business days at an accredited independent lab, depending on the complexity of the formulation and the methods required. Brands that build Amazon launch timelines without accounting for testing lead time end up either rushing decisions or going live before documentation is finalized. Neither outcome is good.

Before You List, or Before You Relist

If a listing has been suspended, the reinstatement path almost invariably runs through a fresh round of third-party testing. Amazon typically won’t accept prior-lot documentation on a relisting review, and internal quality records won’t substitute for accredited third-party COAs.

If you’re launching a new product, structure your production timeline so that testing is complete — and the COA is reviewed internally — at least two weeks before your planned Amazon go-live date. A failing result you catch internally is a manufacturing quality problem you can address before launch. A failing result that Amazon catches is a listing suspension, a potential account health flag, and, depending on the nature of the failure, a possible mandatory recall discussion.

The difference between those two outcomes is entirely about when you decide to look.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• Understanding FDA Audit Readiness for Supplement Manufacturers — Aurora TIC covers 21 CFR compliance consulting and FDA inspection preparation for regulated manufacturers.
• Supplier COA Verification and Raw Material Testing for Supplement Ingredients — Ayah Labs specializes in raw material qualification and COA verification for global ingredient supply chains.
• Dietary Supplement NHP Testing and Health Canada Compliance — Androxa supports supplement brands navigating Canadian NHP registration and GMP requirements.